Papers: 30 Apr 2012 - 7 May 2012
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
In vitro screening of NADPH oxidase inhibitors and in vivo effects of L-leucinethiol on experimental autoimmune encephalomyelitis-induced mice.
Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy.
The "liberation procedure" for multiple sclerosis: sacrificing science at the altar of consumer demand.
Capture-Recapture as a Potentially Useful Procedure for Assessing Prevalence of Multiple Sclerosis: Methodologic Exercise Using Portuguese Data.
Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice.
Acute disseminated encephalomyelitis in Siriraj Hospital: clinical manifestations and short-term outcome.
Neurologic complications in patients with inflammatory bowel disease: Increasing relevance in the era of biologics.
The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population.
Ceramide Synthase 6 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis.
Autoinflammatory grey matter lesions in humans: cortical encephalitis, clinical disorders, experimental models.
The Role of ATP-Binding Cassette Transporters in Neuro-Inflammation: Relevance for Bioactive Lipids.
Cost-effectiveness analysis of interferon Beta-1b for the treatment of patients with a first clinical event suggestive of multiple sclerosis.
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.